Your Article Summary
See Latest ArticlesParstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury
Cardiovascular Research, 06/30/09
Strande JL et al. - A single treatment of parstatin administered prior to ischaemia confers immediate cardioprotection by recruiting the Gi-protein activation pathway including p38 MAPK, ERK1/2, NOS, and KATP channels. Parstatin exerts effects on both the cardiomyocytes and the coronary circulation to induce cardioprotection. This suggests a potential therapeutic role of parstatin in the treatment of cardiac injury resulting from ischaemia and reperfusion.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Right ventricular systolic function and cardiac resynchronization therapy
Europace, 12/18/09
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
The American Journal of Cardiology, 12/18/09
Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy
Europace, 12/18/09